Clinical trial
A Pilot, Feasibility Study of Curcumin in Combination With 5FU for Patients With 5FU-Resistant Metastatic Colon Cancer
NCT02724202 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot, Feasibility Study of Curcumin in Combination With 5FU for Patients With 5FU-Resistant Metastatic Colon Cancer
- Lead sponsor
- Baylor Research Institute
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- February 20, 2018
- Completion date
- January 10, 2020
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic colon cancer